share_log

Decoding 5 Analyst Evaluations For Maravai LifeSciences

Benzinga ·  Nov 8, 2024 14:00

Analysts' ratings for Maravai LifeSciences (NASDAQ:MRVI) over the last quarter vary from bullish to bearish, as provided by 5 analysts.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings03200
Last 30D01000
1M Ago00000
2M Ago00100
3M Ago02100

Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.2, a high estimate of $15.00, and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.27%.

bigjpg

Breaking Down Analyst Ratings: A Detailed Examination

A clear picture of Maravai LifeSciences's perception among financial experts is painted...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment